Global Nerve Repair and Regeneration Devices Market to Reach $12.9 Billion by 2027 – Yahoo Finance

ReportLinker

Abstract: Whats New for 2022?? Global competitiveness and key competitor percentage market shares. Market presence across multiple geographies - Strong/Active/Niche/Trivial.

New York, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nerve Repair and Regeneration Devices Industry" - https://www.reportlinker.com/p05957490/?utm_source=GNW

Online interactive peer-to-peer collaborative bespoke updates

Access to our digital archives and MarketGlass Research Platform

Complimentary updates for one yearGlobal Nerve Repair and Regeneration Devices Market to Reach $12.9 Billion by 2027- In the changed post COVID-19 business landscape, the global market for Nerve Repair and Regeneration Devices estimated at US$6.6 Billion in the year 2020, is projected to reach a revised size of US$12.9 Billion by 2027, growing at aCAGR of 10% over the period 2020-2027. Neurostimulation & Neuromodulation Devices, one of the segments analyzed in the report, is projected to record 9.7% CAGR and reach US$10.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Biomaterials segment is readjusted to a revised 11.7% CAGR for the next 7-year period.- The U.S. Market is Estimated at $2 Billion, While China is Forecast to Grow at 13% CAGR- The Nerve Repair and Regeneration Devices market in the U.S. is estimated at US$2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2027 trailing a CAGR of 13% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.7% and 8.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.

Select Competitors (Total 61 Featured)Abbott Laboratories, Inc.AxoGen, Inc.Boston Scientific CorporationIntegra LifeSciences CorporationLivaNova, PLCMedtronic plcNeuroPace, Inc.Nevro Corporation.Orthomed S.A.S.Polyganics B.V.Stryker CorporationSynapse Biomedical Inc.Synovis Micro Companies Alliance, Inc.

Read the full report: https://www.reportlinker.com/p05957490/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY1. GLOBAL MARKET OVERVIEWImpact of Covid-19 and a Looming Global Recession2020 Marked as a Year of Disruption & TransformationWorld Economic Growth Projections (Real GDP, Annual % Change)for 2019 to 2022Global Nerve Repair & Regeneration Market Buckles under COVID-19 StrainCovid-19 Patients in Prone Position Suffering Nerve DamageBodes Well for Market GrowthNerve Repair and Regeneration Market Set for a Robust GrowthNeurostimulation & Neuromodulation Devices Hold Commanding Slotin Nerve Repair & Regeneration MarketBiomaterials to Exhibit Rapid GrowthNerve Repair and Regeneration Market by ApplicationUS and Europe Dominate the MarketAsia-Pacific and other Emerging Regions Display ImpressiveGrowth PotentialRecent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERSHigh Incidence of Neurological Disorders: A Key Market DriverAnnual Incidence of Adult-Onset Neurologic Disorders in the USEffects of COVID-19 on the Nervous System Sheds Focus onNeuromodulation ApplicationsIncreasing Cases of Peripheral Nerve Injuries Drive the NerveRepair and Regeneration MarketGrowing Number of Vehicular Accidents Drive the PeripheralNerve injuries Repair MarketRising Geriatric Population and Subsequent Growth in PrevalenceOf Neurological DisordersGlobal Population Statistics for the 65+ Age Group in Millionby Geographic Region for the Years 2019, 2025, 2035 and 2050Growing Incidence of Neurodegenerative Diseases Propels theMarket for Deep Brain Stimulation DevicesGlobal Alzheimers Prevalence by Age GroupDiagnosed Prevalence Cases of Parkinson?s Disease Across SelectCountriesGlobal DBS Market by Leading Player (2020E): Market ShareBreakdown of Revenues for Medtronic, Boston Scientific, andAbbottSelect Available Deep Brain Stimulation Devices Available inthe MarketIntensified Research Activity Across Various Neural DisciplinesInduces Additional OptimismStem Cell Therapy: A Promising Avenue for Nerve Repair andRegenerationIncreasing Cases of Epilepsy Drives the Demand for Vagus NerveStimulation DevicesEpilepsy Incidence by Type (2019): Percentage Share Breakdownfor Idiopathic and Symptomatic EpilepsySymptomatic Epilepsy Incidence by Type (2019): Percentage ShareBreakdown of Congenital, Degenerative, Infective, Neoplastic,Trauma, and Vascular EpilepsySpinal Cord Injuries Propel the Demand for Spinal CordStimulation DevicesRecent Developments in Spinal Cord Injury TreatmentBiomaterials (Nerve Conduits and Nerve Wraps) to Witness RapidGrowthNew Biomaterials Pave the Way for Innovative NeurodegenerationTherapiesRole of Nerve Conduits in the Treatment of Peripheral Nerve InjuryInnovative Nerve Conduits from StrykerTENS (Transcutaneous electrical nerve stimulation devices)Market Witnesses Rapid GrowthNon-Invasiveness of TMS (Transcranial Magnetic Stimulation)Propelling the adoption of TMS devicesNerve Grafts for Bridging Larger Nerve GapsRole of Nerve Grafting in Treatment of Peripheral Nerve InjuriesFDA-approved Nerve Tubes for Peripheral Nerve Repair

4. GLOBAL MARKET PERSPECTIVETable 1: World Recent Past, Current & Future Analysis for NerveRepair and Regeneration Devices by Geographic Region - USA,Canada, Japan, China, Europe, Asia-Pacific, Latin America,Middle East and Africa Markets - Independent Analysis of AnnualSales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Nerve Repair andRegeneration Devices by Geographic Region - USA, Canada, Japan,China, Europe, Asia-Pacific, Latin America, Middle East andAfrica Markets - Independent Analysis of Annual Sales in US$Thousand for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Nerve Repair andRegeneration Devices by Geographic Region - PercentageBreakdown of Value Sales for USA, Canada, Japan, China, Europe,Asia-Pacific, Latin America, Middle East and Africa Markets forYears 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis forNeurostimulation & Neuromodulation Devices by Geographic Region -USA, Canada, Japan, China, Europe, Asia-Pacific, LatinAmerica, Middle East and Africa Markets - Independent Analysisof Annual Sales in US$ Thousand for Years 2020 through 2027and % CAGR

Table 5: World Historic Review for Neurostimulation &Neuromodulation Devices by Geographic Region - USA, Canada,Japan, China, Europe, Asia-Pacific, Latin America, Middle Eastand Africa Markets - Independent Analysis of Annual Sales inUS$ Thousand for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Neurostimulation &Neuromodulation Devices by Geographic Region - PercentageBreakdown of Value Sales for USA, Canada, Japan, China, Europe,Asia-Pacific, Latin America, Middle East and Africa for Years2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis forBiomaterials by Geographic Region - USA, Canada, Japan, China,Europe, Asia-Pacific, Latin America, Middle East and AfricaMarkets - Independent Analysis of Annual Sales in US$ Thousandfor Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Biomaterials by GeographicRegion - USA, Canada, Japan, China, Europe, Asia-Pacific, LatinAmerica, Middle East and Africa Markets - Independent Analysisof Annual Sales in US$ Thousand for Years 2012 through 2019and % CAGR

Table 9: World 15-Year Perspective for Biomaterials byGeographic Region - Percentage Breakdown of Value Sales forUSA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis forNeurostimulation & Neuromodulation Surgeries by GeographicRegion - USA, Canada, Japan, China, Europe, Asia-Pacific, LatinAmerica, Middle East and Africa Markets - Independent Analysisof Annual Sales in US$ Thousand for Years 2020 through 2027and % CAGR

Table 11: World Historic Review for Neurostimulation &Neuromodulation Surgeries by Geographic Region - USA, Canada,Japan, China, Europe, Asia-Pacific, Latin America, Middle Eastand Africa Markets - Independent Analysis of Annual Sales inUS$ Thousand for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Neurostimulation &Neuromodulation Surgeries by Geographic Region - PercentageBreakdown of Value Sales for USA, Canada, Japan, China, Europe,Asia-Pacific, Latin America, Middle East and Africa for Years2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis forNeurorrhaphy by Geographic Region - USA, Canada, Japan, China,Europe, Asia-Pacific, Latin America, Middle East and AfricaMarkets - Independent Analysis of Annual Sales in US$ Thousandfor Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Neurorrhaphy by GeographicRegion - USA, Canada, Japan, China, Europe, Asia-Pacific, LatinAmerica, Middle East and Africa Markets - Independent Analysisof Annual Sales in US$ Thousand for Years 2012 through 2019and % CAGR

Table 15: World 15-Year Perspective for Neurorrhaphy byGeographic Region - Percentage Breakdown of Value Sales forUSA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,Middle East and Africa for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis forNerve Grafting by Geographic Region - USA, Canada, Japan,China, Europe, Asia-Pacific, Latin America, Middle East andAfrica Markets - Independent Analysis of Annual Sales in US$Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Nerve Grafting byGeographic Region - USA, Canada, Japan, China, Europe,Asia-Pacific, Latin America, Middle East and Africa Markets -Independent Analysis of Annual Sales in US$ Thousand for Years2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Nerve Grafting byGeographic Region - Percentage Breakdown of Value Sales forUSA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,Middle East and Africa for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for StemCell Therapy by Geographic Region - USA, Canada, Japan, China,Europe, Asia-Pacific, Latin America, Middle East and AfricaMarkets - Independent Analysis of Annual Sales in US$ Thousandfor Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Stem Cell Therapy byGeographic Region - USA, Canada, Japan, China, Europe,Asia-Pacific, Latin America, Middle East and Africa Markets -Independent Analysis of Annual Sales in US$ Thousand for Years2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Stem Cell Therapy byGeographic Region - Percentage Breakdown of Value Sales forUSA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,Middle East and Africa for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis forHospitals & Clinics by Geographic Region - USA, Canada, Japan,China, Europe, Asia-Pacific, Latin America, Middle East andAfrica Markets - Independent Analysis of Annual Sales in US$Thousand for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Hospitals & Clinics byGeographic Region - USA, Canada, Japan, China, Europe,Asia-Pacific, Latin America, Middle East and Africa Markets -Independent Analysis of Annual Sales in US$ Thousand for Years2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Hospitals & Clinics byGeographic Region - Percentage Breakdown of Value Sales forUSA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,Middle East and Africa for Years 2012, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis forAmbulatory Surgery Centers by Geographic Region - USA, Canada,Japan, China, Europe, Asia-Pacific, Latin America, Middle Eastand Africa Markets - Independent Analysis of Annual Sales inUS$ Thousand for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Ambulatory Surgery Centersby Geographic Region - USA, Canada, Japan, China, Europe,Asia-Pacific, Latin America, Middle East and Africa Markets -Independent Analysis of Annual Sales in US$ Thousand for Years2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Ambulatory SurgeryCenters by Geographic Region - Percentage Breakdown of ValueSales for USA, Canada, Japan, China, Europe, Asia-Pacific,Latin America, Middle East and Africa for Years 2012, 2021 &2027Impact of Covid-19 and a Looming Global Recession

III. MARKET ANALYSIS

UNITED STATESNerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Statesfor 2022 (E)Table 28: USA Recent Past, Current & Future Analysis for NerveRepair and Regeneration Devices by Product - Neurostimulation &Neuromodulation Devices and Biomaterials - Independent Analysisof Annual Sales in US$ Thousand for the Years 2020 through 2027and % CAGR

Table 29: USA Historic Review for Nerve Repair and RegenerationDevices by Product - Neurostimulation & Neuromodulation Devicesand Biomaterials Markets - Independent Analysis of Annual Salesin US$ Thousand for Years 2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Nerve Repair andRegeneration Devices by Product - Percentage Breakdown of ValueSales for Neurostimulation & Neuromodulation Devices andBiomaterials for the Years 2012, 2021 & 2027

Table 31: USA Recent Past, Current & Future Analysis for NerveRepair and Regeneration Devices by Application -Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy,Nerve Grafting and Stem Cell Therapy - Independent Analysis ofAnnual Sales in US$ Thousand for the Years 2020 through 2027and % CAGR

Table 32: USA Historic Review for Nerve Repair and RegenerationDevices by Application - Neurostimulation & NeuromodulationSurgeries, Neurorrhaphy, Nerve Grafting and Stem Cell TherapyMarkets - Independent Analysis of Annual Sales in US$ Thousandfor Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Nerve Repair andRegeneration Devices by Application - Percentage Breakdown ofValue Sales for Neurostimulation & Neuromodulation Surgeries,Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for theYears 2012, 2021 & 2027

Table 34: USA Recent Past, Current & Future Analysis for NerveRepair and Regeneration Devices by End-Use - Hospitals &Clinics and Ambulatory Surgery Centers - Independent Analysisof Annual Sales in US$ Thousand for the Years 2020 through 2027and % CAGR

Table 35: USA Historic Review for Nerve Repair and RegenerationDevices by End-Use - Hospitals & Clinics and Ambulatory SurgeryCenters Markets - Independent Analysis of Annual Sales in US$Thousand for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Nerve Repair andRegeneration Devices by End-Use - Percentage Breakdown of ValueSales for Hospitals & Clinics and Ambulatory Surgery Centersfor the Years 2012, 2021 & 2027

CANADATable 37: Canada Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by Product -Neurostimulation & Neuromodulation Devices and Biomaterials -Independent Analysis of Annual Sales in US$ Thousand for theYears 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Nerve Repair andRegeneration Devices by Product - Neurostimulation &Neuromodulation Devices and Biomaterials Markets - IndependentAnalysis of Annual Sales in US$ Thousand for Years 2012 through2019 and % CAGR

Table 39: Canada 15-Year Perspective for Nerve Repair andRegeneration Devices by Product - Percentage Breakdown of ValueSales for Neurostimulation & Neuromodulation Devices andBiomaterials for the Years 2012, 2021 & 2027

Table 40: Canada Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by Application -Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy,Nerve Grafting and Stem Cell Therapy - Independent Analysis ofAnnual Sales in US$ Thousand for the Years 2020 through 2027and % CAGR

Table 41: Canada Historic Review for Nerve Repair andRegeneration Devices by Application - Neurostimulation &Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting andStem Cell Therapy Markets - Independent Analysis of AnnualSales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 42: Canada 15-Year Perspective for Nerve Repair andRegeneration Devices by Application - Percentage Breakdown ofValue Sales for Neurostimulation & Neuromodulation Surgeries,Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for theYears 2012, 2021 & 2027

Table 43: Canada Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by End-Use - Hospitals &Clinics and Ambulatory Surgery Centers - Independent Analysisof Annual Sales in US$ Thousand for the Years 2020 through 2027and % CAGR

Table 44: Canada Historic Review for Nerve Repair andRegeneration Devices by End-Use - Hospitals & Clinics andAmbulatory Surgery Centers Markets - Independent Analysis ofAnnual Sales in US$ Thousand for Years 2012 through 2019 and %CAGR

Table 45: Canada 15-Year Perspective for Nerve Repair andRegeneration Devices by End-Use - Percentage Breakdown of ValueSales for Hospitals & Clinics and Ambulatory Surgery Centersfor the Years 2012, 2021 & 2027

JAPANNerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)Table 46: Japan Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by Product -Neurostimulation & Neuromodulation Devices and Biomaterials -Independent Analysis of Annual Sales in US$ Thousand for theYears 2020 through 2027 and % CAGR

Table 47: Japan Historic Review for Nerve Repair andRegeneration Devices by Product - Neurostimulation &Neuromodulation Devices and Biomaterials Markets - IndependentAnalysis of Annual Sales in US$ Thousand for Years 2012 through2019 and % CAGR

Table 48: Japan 15-Year Perspective for Nerve Repair andRegeneration Devices by Product - Percentage Breakdown of ValueSales for Neurostimulation & Neuromodulation Devices andBiomaterials for the Years 2012, 2021 & 2027

Table 49: Japan Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by Application -Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy,Nerve Grafting and Stem Cell Therapy - Independent Analysis ofAnnual Sales in US$ Thousand for the Years 2020 through 2027and % CAGR

Table 50: Japan Historic Review for Nerve Repair andRegeneration Devices by Application - Neurostimulation &Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting andStem Cell Therapy Markets - Independent Analysis of AnnualSales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Nerve Repair andRegeneration Devices by Application - Percentage Breakdown ofValue Sales for Neurostimulation & Neuromodulation Surgeries,Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for theYears 2012, 2021 & 2027

Table 52: Japan Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by End-Use - Hospitals &Clinics and Ambulatory Surgery Centers - Independent Analysisof Annual Sales in US$ Thousand for the Years 2020 through 2027and % CAGR

Table 53: Japan Historic Review for Nerve Repair andRegeneration Devices by End-Use - Hospitals & Clinics andAmbulatory Surgery Centers Markets - Independent Analysis ofAnnual Sales in US$ Thousand for Years 2012 through 2019 and %CAGR

Table 54: Japan 15-Year Perspective for Nerve Repair andRegeneration Devices by End-Use - Percentage Breakdown of ValueSales for Hospitals & Clinics and Ambulatory Surgery Centersfor the Years 2012, 2021 & 2027

CHINANerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)Table 55: China Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by Product -Neurostimulation & Neuromodulation Devices and Biomaterials -Independent Analysis of Annual Sales in US$ Thousand for theYears 2020 through 2027 and % CAGR

Table 56: China Historic Review for Nerve Repair andRegeneration Devices by Product - Neurostimulation &Neuromodulation Devices and Biomaterials Markets - IndependentAnalysis of Annual Sales in US$ Thousand for Years 2012 through2019 and % CAGR

Table 57: China 15-Year Perspective for Nerve Repair andRegeneration Devices by Product - Percentage Breakdown of ValueSales for Neurostimulation & Neuromodulation Devices andBiomaterials for the Years 2012, 2021 & 2027

Table 58: China Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by Application -Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy,Nerve Grafting and Stem Cell Therapy - Independent Analysis ofAnnual Sales in US$ Thousand for the Years 2020 through 2027and % CAGR

Table 59: China Historic Review for Nerve Repair andRegeneration Devices by Application - Neurostimulation &Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting andStem Cell Therapy Markets - Independent Analysis of AnnualSales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Nerve Repair andRegeneration Devices by Application - Percentage Breakdown ofValue Sales for Neurostimulation & Neuromodulation Surgeries,Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for theYears 2012, 2021 & 2027

Table 61: China Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by End-Use - Hospitals &Clinics and Ambulatory Surgery Centers - Independent Analysisof Annual Sales in US$ Thousand for the Years 2020 through 2027and % CAGR

Table 62: China Historic Review for Nerve Repair andRegeneration Devices by End-Use - Hospitals & Clinics andAmbulatory Surgery Centers Markets - Independent Analysis ofAnnual Sales in US$ Thousand for Years 2012 through 2019 and %CAGR

Table 63: China 15-Year Perspective for Nerve Repair andRegeneration Devices by End-Use - Percentage Breakdown of ValueSales for Hospitals & Clinics and Ambulatory Surgery Centersfor the Years 2012, 2021 & 2027

EUROPENerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)Table 64: Europe Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by Geographic Region -France, Germany, Italy, UK, Spain, Russia and Rest of EuropeMarkets - Independent Analysis of Annual Sales in US$ Thousandfor Years 2020 through 2027 and % CAGR

Table 65: Europe Historic Review for Nerve Repair andRegeneration Devices by Geographic Region - France, Germany,Italy, UK, Spain, Russia and Rest of Europe Markets -Independent Analysis of Annual Sales in US$ Thousand for Years2012 through 2019 and % CAGR

Table 66: Europe 15-Year Perspective for Nerve Repair andRegeneration Devices by Geographic Region - PercentageBreakdown of Value Sales for France, Germany, Italy, UK, Spain,Russia and Rest of Europe Markets for Years 2012, 2021 & 2027

Table 67: Europe Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by Product -Neurostimulation & Neuromodulation Devices and Biomaterials -Independent Analysis of Annual Sales in US$ Thousand for theYears 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Nerve Repair andRegeneration Devices by Product - Neurostimulation &Neuromodulation Devices and Biomaterials Markets - IndependentAnalysis of Annual Sales in US$ Thousand for Years 2012 through2019 and % CAGR

Table 69: Europe 15-Year Perspective for Nerve Repair andRegeneration Devices by Product - Percentage Breakdown of ValueSales for Neurostimulation & Neuromodulation Devices andBiomaterials for the Years 2012, 2021 & 2027

Table 70: Europe Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by Application -Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy,Nerve Grafting and Stem Cell Therapy - Independent Analysis ofAnnual Sales in US$ Thousand for the Years 2020 through 2027and % CAGR

Table 71: Europe Historic Review for Nerve Repair andRegeneration Devices by Application - Neurostimulation &Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting andStem Cell Therapy Markets - Independent Analysis of AnnualSales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Nerve Repair andRegeneration Devices by Application - Percentage Breakdown ofValue Sales for Neurostimulation & Neuromodulation Surgeries,Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for theYears 2012, 2021 & 2027

Table 73: Europe Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by End-Use - Hospitals &Clinics and Ambulatory Surgery Centers - Independent Analysisof Annual Sales in US$ Thousand for the Years 2020 through 2027and % CAGR

Table 74: Europe Historic Review for Nerve Repair andRegeneration Devices by End-Use - Hospitals & Clinics andAmbulatory Surgery Centers Markets - Independent Analysis ofAnnual Sales in US$ Thousand for Years 2012 through 2019 and %CAGR

Table 75: Europe 15-Year Perspective for Nerve Repair andRegeneration Devices by End-Use - Percentage Breakdown of ValueSales for Hospitals & Clinics and Ambulatory Surgery Centersfor the Years 2012, 2021 & 2027

FRANCENerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)Table 76: France Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by Product -Neurostimulation & Neuromodulation Devices and Biomaterials -Independent Analysis of Annual Sales in US$ Thousand for theYears 2020 through 2027 and % CAGR

Table 77: France Historic Review for Nerve Repair andRegeneration Devices by Product - Neurostimulation &Neuromodulation Devices and Biomaterials Markets - IndependentAnalysis of Annual Sales in US$ Thousand for Years 2012 through2019 and % CAGR

Table 78: France 15-Year Perspective for Nerve Repair andRegeneration Devices by Product - Percentage Breakdown of ValueSales for Neurostimulation & Neuromodulation Devices andBiomaterials for the Years 2012, 2021 & 2027

Table 79: France Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by Application -Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy,Nerve Grafting and Stem Cell Therapy - Independent Analysis ofAnnual Sales in US$ Thousand for the Years 2020 through 2027and % CAGR

Table 80: France Historic Review for Nerve Repair andRegeneration Devices by Application - Neurostimulation &Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting andStem Cell Therapy Markets - Independent Analysis of AnnualSales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 81: France 15-Year Perspective for Nerve Repair andRegeneration Devices by Application - Percentage Breakdown ofValue Sales for Neurostimulation & Neuromodulation Surgeries,Neurorrhaphy, Nerve Grafting and Stem Cell Therapy for theYears 2012, 2021 & 2027

Table 82: France Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by End-Use - Hospitals &Clinics and Ambulatory Surgery Centers - Independent Analysisof Annual Sales in US$ Thousand for the Years 2020 through 2027and % CAGR

Table 83: France Historic Review for Nerve Repair andRegeneration Devices by End-Use - Hospitals & Clinics andAmbulatory Surgery Centers Markets - Independent Analysis ofAnnual Sales in US$ Thousand for Years 2012 through 2019 and %CAGR

Table 84: France 15-Year Perspective for Nerve Repair andRegeneration Devices by End-Use - Percentage Breakdown of ValueSales for Hospitals & Clinics and Ambulatory Surgery Centersfor the Years 2012, 2021 & 2027

GERMANYNerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022:(E)Table 85: Germany Recent Past, Current & Future Analysis forNerve Repair and Regeneration Devices by Product -Neurostimulation & Neuromodulation Devices and Biomaterials -Independent Analysis of Annual Sales in US$ Thousand for theYears 2020 through 2027 and % CAGR

Table 86: Germany Historic Review for Nerve Repair andRegeneration Devices by Product - Neurostimulation &Neuromodulation Devices and Biomaterials Markets - IndependentAnalysis of Annual Sales in US$ Thousand for Years 2012 through2019 and % CAGR

Table 87: Germany 15-Year Perspective for Nerve Repair andRegeneration Devices by Product - Percentage Breakdown of ValueSales for Neurostimulation & Neuromodulation Devices andBiomaterials for the Years 2012, 2021 & 2027

See more here:
Global Nerve Repair and Regeneration Devices Market to Reach $12.9 Billion by 2027 - Yahoo Finance